Sofinnova Investments, Inc. Q3 2022 Filing
Filed November 8, 2022
Portfolio Value
$1.7T
Holdings
55
Report Date
Q3 2022
Filing Type
13F-HR
All Holdings (55 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | KRTXKaruna Therapeutics Inc | 2,073,124 | $466.3B | 27.13% | |
| 2 | —Cincor Pharma Inc | 6,073,949 | $199.3B | 11.60% | |
| 3 | NTRANatera Inc | 3,102,960 | $136.0B | 7.91% | |
| 4 | MRKMerck & Co Inc | 883,468 | $76.1B | 4.43% | Call |
| 5 | VERAVera Therapeutics Inc | 3,181,442 | $67.8B | 3.94% | |
| 6 | AVTEAerovate Therapeutics Inc | 3,758,686 | $62.3B | 3.63% | |
| 7 | ASNDAscendis Pharma A/S | 499,824 | $51.6B | 3.00% | |
| 8 | SNYSanofi SA | 1,264,546 | $48.1B | 2.80% | |
| 9 | NDQInvesco QQQ Trust Series 1 | 150,000 | $40.1B | 2.33% | Put |
| 10 | AZNAstraZeneca PLC | 701,878 | $38.5B | 2.24% | |
| 11 | XLVHealth Care Select Sector SPDR | 300,000 | $36.3B | 2.11% | Put |
| 12 | IWMiShares Russell 2000 ETF | 200,000 | $33.0B | 1.92% | Put |
| 13 | YMABUSDY-mAbs Therapeutics Inc | 2,194,278 | $31.6B | 1.84% | |
| 14 | UTHUnited Therapeutics Corp | 147,564 | $30.9B | 1.80% | |
| 15 | GILDGilead Sciences Inc | 482,400 | $29.8B | 1.73% | |
| 16 | BMRNBiomarin Pharmaceutical Inc | 294,750 | $25.0B | 1.45% | |
| 17 | CTIC1USDCTI Biopharma Corp | 3,612,376 | $21.0B | 1.22% | |
| 18 | RETAEURReata Pharmaceuticals Inc | 818,376 | $20.6B | 1.20% | |
| 19 | ISRGIntuitive Surgical Inc | 96,300 | $18.1B | 1.05% | |
| 20 | IRTCiRhythm Technologies Inc | 140,095 | $17.6B | 1.02% | |
| 21 | DC4Dexcom Inc | 205,948 | $16.6B | 0.97% | |
| 22 | SRPTSarepta Therapeutics Inc | 141,440 | $15.6B | 0.91% | |
| 23 | CYTKCytokinetics Inc | 320,722 | $15.5B | 0.90% | |
| 24 | OPHTEURIveric Bio Inc | 820,665 | $14.7B | 0.86% | |
| 25 | LLYLilly Eli & Co | 45,500 | $14.7B | 0.86% | |
| 26 | INBXUSDInhibrx Inc | 800,177 | $14.4B | 0.84% | Put |
| 27 | ZNTLZentalis Pharmaceuticals Inc | 583,357 | $12.6B | 0.74% | |
| 28 | SNDXSyndax Pharmaceuticals Inc | 525,002 | $12.6B | 0.73% | |
| 29 | EWEdwards Lifesciences Corp | 147,200 | $12.2B | 0.71% | |
| 30 | —Akouos Inc | 1,515,074 | $10.2B | 0.60% | |
| 31 | RCUSArcus Biosciences Inc | 381,345 | $10.0B | 0.58% | |
| 32 | INZYInozyme Pharm Inc | 3,655,308 | $9.8B | 0.57% | |
| 33 | IDYAIDEAYA Biosciences Inc | 654,756 | $9.8B | 0.57% | |
| 34 | TVTXTravere Therapeutics Inc | 394,678 | $9.7B | 0.57% | |
| 35 | —Prometheus Biosciences Inc | 139,774 | $8.2B | 0.48% | |
| 36 | NXTCNextcure Inc | 2,671,856 | $7.3B | 0.43% | |
| 37 | TORCEURAdicet Bio Inc | 491,965 | $7.0B | 0.41% | |
| 38 | FULCFulcrum Therapeutics Inc | 797,262 | $6.5B | 0.38% | |
| 39 | —Nucana Biomed | 5,599,999 | $5.9B | 0.34% | |
| 40 | 290AChinook Therapeutics Inc | 287,901 | $5.7B | 0.33% | |
| 41 | RGNXRegenxbio Inc | 213,959 | $5.7B | 0.33% | |
| 42 | GRTXGalera Therapeutics Inc | 3,083,712 | $5.4B | 0.31% | |
| 43 | IMTXImmatics NV | 532,516 | $5.3B | 0.31% | |
| 44 | GONGeron Corp | 2,261,308 | $5.3B | 0.31% | Call |
| 45 | ARQTArcutis Biotherapeutics Inc | 274,330 | $5.2B | 0.30% | |
| 46 | AGENEURAgenus Inc | 2,437,465 | $5.0B | 0.29% | |
| 47 | IM8NInsmed Inc | 220,665 | $4.8B | 0.28% | |
| 48 | BOLT1EURBolt Biotherapeutics Inc | 2,754,437 | $4.1B | 0.24% | |
| 49 | —Nucana Biomed | 2,400,000 | $2.5B | 0.15% | |
| 50 | IMGNEURImmunoGen Inc | 502,393 | $2.4B | 0.14% | |
| 51 | NGMUSDNGM Biopharmaceuticals Inc | 150,000 | $2.0B | 0.11% | Call |
| 52 | —ObsEva SA | 4,749,623 | $675.0M | 0.04% | |
| 53 | —Synlogic Inc | 574,972 | $546.0M | 0.03% | |
| 54 | PDSBPDS Biotechnology Corporation | 142,635 | $424.0M | 0.02% | |
| 55 | —Fusion Pharmaceuticals Inc | 117,099 | $352.0M | 0.02% | |
| 56 | —CinCor Pharma Inc | 6,000 | $197.0M | 0.01% |